Urinary Catheters Market Size, Share, and Growth Forecast for 2025 - 2032

The global urinary catheters market is predicted to reach a size of US$ 2.1 Bn by 2025. It is anticipated to witness a CAGR of 5.6% during the forecast period to attain a value of US$ 3.1 Bn by 2032.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), around 25% of adults aged 65 and above experience urinary incontinence, leading to a rising need for urinary catheters. Aging population is a significant contributor to growth of the urinary catheter industry. Rise in home healthcare services is bolstering demand for user friendly and portable urinary catheter solutions.

Patients managing chronic conditions prefer self-catheterization, leading to popularity of intermittent urinary catheters. Antimicrobial catheters are witnessing rising demand as they reduce the risk of catheter associated urinary tract infections (CAUTIs). Studies indicate that antimicrobial catheters can decrease infection rates by 30% compared to standard catheters.

Key Highlights of the Industry

• Hydrophilic coatings are witnessing rising demand as these decrease friction while minimizing discomfort during insertion and removal.
• Increased preference for disposable and single-use catheters owing to rising awareness regarding friction control and hygiene is set to boost growth.
• Male external catheters or condom catheters are gaining traction owing to their non-invasive nature and lower risk of infection.
• Closed system catheters are experiencing growth as these are designed to maintain sterility, further minimizing the risk of infections.
• The World Health Organization (WHO) estimates that the population aged 65 and above is estimated to reach 1.5 by 2050, fueling demand for catheters designed for long-term and intermittent use.
• Rising prevalence of bladder dysfunctions and prostate enlargement are the key growth drivers.
• By product, the intermittent catheter segment is predicted to exhibit a CAGR of 5.4% through 2032 as these help minimize the risk of CAUTIs.
• Based on type, the coated catheters segment is predicted to hold a share of 60.4% in 2025 as these lower the risk of infections.
• The urinary catheters market in North America is set to hold a share of 38.7% in 2025 owing to increasing aging population in the region.

North America urinary catheters market is estimated to hold a share of 38.7% in 2025 and witness a CAGR of 4.1% through 2032. Urological conditions like urinary retention, incontinence, and bladder dysfunction are highly prevalent in the region. For example,

• According to the National Association for Continence (NAFC), nearly 25 million Americans witness urinary incontinence, a significant factor driving demand for urinary catheters.

The aging population of the region is particularly affected with over 30% of men and women aged 65 and above predicted to have some form of urinary incontinence. This fuels the need for intermittent and indwelling catheters.

• According to the U.S. Census Bureau, the population aged 65 and older in the U.S. reached 56 million in 2020 and is predicted to grow to 73 million by 2030.

Older adults are predicted to require long-term catheterization, supporting the growth of urinary catheter market in the region. Availability of skilled healthcare professionals in the region ensures the widespread adoption of catheters in hospitals and clinics.

Intermittent catheter is anticipated to hold a share of 54% in 2025. These catheters are designed for temporary use, thereby minimizing the risk of catheter associated urinary tract infections (CAUTIs).

• A study published in the Journal of Urology found that patients using intermittent catheters experienced a 30% lower risk of UTIs compared to those using indwelling catheters.

Hospitals and healthcare providers recommend intermittent catheterization as a safer alternative, driving the demand for clinical and home care settings. Intermittent catheters are user-friendly and designed for self-catheterization, making these ideal for patients managing chronic conditions at home. For instance,

• The National Home Care and Hospice Association reports that over 12 million Americans receive home healthcare annually, and intermittent catheters are among the most commonly used devices.

Coated catheters are projected to account for a share of 60.4% in 2025. Coated catheters, like antimicrobial-coated and hydrophilic-coated types, lower the risk of infections compared to uncoated catheters. For example,

• The Centers for Disease Control and Prevention (CDC) estimates that 12% to 16% of hospitalized patients undergo urinary catheterization, making them susceptible to CAUTIs. Coated catheters have been shown to decrease this risk by 40% to 70%.

Antimicrobial coatings prevent bacterial adhesion, while hydrophilic coatings decrease friction, lowering irritation and infection risk. Hydrophilic-coated catheters feature a lubricating layer activated by water, minimizing friction during insertion and removal. This makes them particularly suitable for patients requiring frequent catheterization. For instance,

• A study published in the Journal of Clinical Urology found that hydrophilic-coated catheters reduced discomfort in 85% of patients compared to standard catheters.

Potential growth in the global urinary catheters industry is predicted to be driven by an emphasis on user-friendly designs and compact products for home based. Smart catheters with IoT enabled monitoring are likely to gain traction in hospitals as well as home care settings. Manufacturers are set to invest in biodegradable and environmentally friendly catheter materials to align with global sustainability goals.

The urinary catheters market growth was steady at a CAGR of 4.8% during the historical period from 2019 to 2023. Increased awareness and improved healthcare access in developed as well as emerging markets drove growth. For example,

• According to the World Health Organization (WHO), around 420 million people globally witnessed urinary incontinence or bladder dysfunction in 2023, up from 390 million in 2019.

Growing geriatric population in North America, Europe, and Asia Pacific fueled demand for urinary catheters as older adults are more prone to blood-related conditions. A shift toward self-catheterization for managing chronic conditions contributed to expansion.

Growth during the forecast period is likely to be driven by rising adoption of novel technologies in the field. Development of healthcare infrastructure in emerging markets is likely to augment demand.

Increased Focus on Homebased Care

Conditions like urinary incontinence, neurogenic bladder, and benign prostatic hyperplasia (BPH) often require long term management using urinary catheters. For example,

• According to the National Association for Continence (NAFC), around 70% of patients with urinary incontinence prefer self-catheterization over relying on healthcare providers for assistance.

Self-catheterization has become a popular option for patients requiring intermittent catheterization owing to convenience and cost-effectiveness. Innovations like hydrophilic coated catheters are easy to use and decrease discomfort, boosting their adoption in home settings. For instance,

• The Agency for Healthcare Research and Quality (AHRQ) reports that home healthcare is 30% to 50% more cost-effective than institutional care.

Favorable Reimbursement Policies

Several countries include intermittent, indwelling, and external urinary catheters in their healthcare reimbursement frameworks. This ensures that patients can access necessary products without incurring substantial out-of-pocket expenses. For example,

• In the U.S., Medicare Part B and private insurance plans cover intermittent catheterization supplies for individuals with permanent urological conditions.

Coverage includes 200 catheters per month for eligible patients. Catheters with sterile packaging or coatings are also reimbursable if deemed medically necessary. For example,

• In Canada, provincial health programs like the Assistive Devices Program (ADP) in Ontario provide coverage for urinary catheters, decreasing the financial burden on patients.
• Hydrophilic-coated catheters, known for decreasing catheter-associated urinary tract infections (CAUTIs), saw a 12% higher adoption rate in regions with comprehensive reimbursement policies.

High Cost of Innovative Catheters

Cost of unique catheters, like hydrophilic-coated, antimicrobial-coated, and silicone catheters, is higher than traditional catheters. This makes them less accessible in regions with budget constraints, like in emerging economies or underfunded healthcare systems. For example,

• Based on data obtained from prominent manufacturers, advanced catheters can cost up to 50% to 100% more than standard uncoated catheters.

High cost of these products is likely to limit their widespread adoption, especially in cost-sensitive markets.

Awareness Campaigns and Educational Initiatives

Campaigns focusing on conditions like urinary incontinence, neurogenic bladder, and prostate issues are educating the public on the importance of timely diagnosis and management. Manufacturers and healthcare providers are organizing workshops, webinars, and tutorials to train patients and caregivers in proper catheter usage. For example,

• Organizations like the World Federation of Incontinence and Pelvic Problems (WFIPP) run global campaigns to address misconceptions and promote the use of medical devices like catheters.

Initiatives targeting healthcare professionals ensure they are equipped to guide patients in choosing the right type of catheter and provide training on its proper use. Training programs also emphasize infection control practices to decrease catheter-associated urinary tract infections (CAUTIs).

• Non-profits and advocacy groups, like the National Association for Continence (NAFC), run annual events and campaigns like "Bladder Health Awareness Month", focusing on the importance of urinary health and the role of catheters in improving quality of life.

Increasing Focus on Infection Prevention

Catheter-associated UTIs are among the most common healthcare associated infections across the globe. For instance,

• According to the Centers for Disease Control and Prevention (CDC), CAUTIs account for 75% of urinary tract infections in hospitals.

The CDC also estimated that 12% to 16% of adult hospitals inpatients will require a urinary catheter during their stay, thereby increasing the risk of infection. In several countries, hospitals may face penalties or decreased reimbursements for avoidable CAUTIs in several countries. For instance,

• Regulatory bodies like the World Health Organization (WHO) and Joint Commission International (JCI) emphasize infection prevention in catheter use.
• Under the Medicare Hospital-Acquired Condition (HAC) Reduction Program, U.S. hospitals may receive decreased reimbursements for CAUTI-related cases.

Companies in the urinary catheters market are focusing on the development of high-performance catheters that offer additional benefits. These features decrease infection risks while improving patient comfort.

Businesses are offering customized solutions to cater to specific requirements. This ensures consumers have a range of choices, thereby increasing satisfaction and demand.

Manufacturers are focusing on disposable catheters owing to the rising need for single use products that decrease the risk of infections. They are focusing on continuous product development of disposable urinary catheters that offer high comfort while decreasing the risk of cross contamination.

Companies are broadening their product portfolio beyond urinary catheters to include complementary products. This includes catheter insertion kits, urinary drainage bags, and continence care products.

Recent Industry Developments

• In January 2024, the California Institute of Technology published a report on how their researchers utilized AI to develop a catheter design that reduced bacterial upstream movement by 100-fold in lab tests. This innovation prevents the use of antibiotics or chemicals, ensuring effective infection prevention.
• In September 2023, the Sage PrimaFit External Urine Management device reduced CAUTI rates by 72%. Clinical Nurse Specialists implemented a quality improvement program to decrease the prevalence and associated harm of catheter-associated urinary tract infections effectively.
• In February 2023, Coloplast launched a male catheter designed to reduce the risk of urinary tract infections. The new product aims to improve patient care by minimizing infection rates associated with catheter use in men.